肾病综合征患者因疑似静脉血栓栓塞行增强CT后急性肾损伤:倾向性评分匹配回顾性队列研究
回顾性纳入701例因疑似静脉血栓栓塞行增强CT的肾病综合征患者及1053例接受平扫CT的对照,采用3变量和10变量1:1倾向性评分匹配后比较CT后急性肾损伤发生率。匹配后两组急性肾损伤发生率无显著差异(标准标准3.1% vs 2.6%,P=0.72;AKIN标准4.1% vs 7.4%,P=0.03),各eGFR亚组增强CT组发生率均不高于平扫CT组。结论认为静脉碘对比剂不是该人群急性肾损伤的危险因素。
要点
- 倾向性评分匹配后增强CT组与平扫CT组急性肾损伤发生率无显著差异。
- 各eGFR亚组中增强CT组急性肾损伤发生率均不高于平扫CT组。
- 缺乏平扫CT对照组的研究可能高估对比剂诱导肾病发生率。
核心结论
- 在肾病综合征患者中,静脉注射碘对比剂行CT检查未被发现是急性肾损伤的危险因素。
研究设计与样本
- 回顾性队列研究,纳入701例因疑似静脉血栓栓塞行增强CT的肾病综合征患者和1053例接受平扫CT的肾病综合征对照,采用3变量和10变量1:1倾向性评分匹配,按eGFR亚组分析,以标准AKI标准和AKIN标准评估CT后急性肾损伤。
诊断标准与关键数值
- 采用标准AKI标准和急性肾损伤网络(AKIN)标准评估CT后急性肾损伤;3变量匹配后增强CT组与平扫CT组AKI发生率分别为2.7% vs 2.5%(标准标准,P=1.00)和4.2% vs 6.7%(AKIN标准,P=0.05)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine whether intravenous iodinated contrast material administration increases the risk of acute kidney injury (AKI) in patients with nephrotic syndrome undergoing contrast-enhanced CT.
METHODS: Patients with nephrotic syndrome undergoing contrast-enhanced CT were retrospectively identified (n = 701). Control group consisted of patients with nephrotic syndrome receiving non-contrast CT (n = 1053). Two different 1:1 propensity score matching models using three or 10 variables were developed for each estimated glomerular filtration (eGFR) subgroup. Incidence of post-CT AKI for the two groups was assessed and compared by standard AKI criteria and Acute Kidney Injury Network (AKIN) criteria.
RESULTS: After matching with three variables, the AKI incidence in the contrast-enhanced CT and non-contrast CT groups was 2.7% vs 2.5% (standard AKI criteria) and 4.2% vs. 6.7% (AKIN criteria) (p = 1.00 and 0.05), respectively. After matching with 10 variables, AKI incidences were 3.1% vs. 2.6% (standard AKI criteria) and 4.1% vs. 7.4% (AKIN criteria) (p = 0.72 and 0.03), respectively. AKI incidences of each eGFR subgroup in the contrast-enhanced CT group were not higher than in the non-contrast CT group (lowest p = 0.46).
CONCLUSION: Intravenous contrast material administration during CT was not found to be a risk factor for AKI in this large cohort of patients with nephrotic syndrome.
KEY POINTS: • AKI incidence of contrast-enhanced CT and non-contrast CT had no difference. • AKI incidences of eGFR subgroup in contrast-enhanced CT were not increased. • Studies without a non-contrast CT control group may overestimate CIN incidence.
引用
- Tao SM, Kong X, Schoepf UJ, et al. Acute kidney injury in patients with nephrotic syndrome undergoing contrast-enhanced CT for suspected venous thromboembolism: a propensity score-matched retrospective cohort study. Eur Radiol. 2017. PMID: 29098438. doi:10.1007/s00330-017-5109-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。